Debra Thoma Vallner, Ph.D., MBA has been our Sr. Vice President of Development Operations since 2022 and has over thirty-five years of experience in drug development.
Previously, Dr. Vallner has held senior leadership positions at Roche, Nektar Therapeutics, Exelixis, Anthera, Anacor and eFFECTOR Therapeutics. Prior to joining Peel, Dr. Vallner served and as VP of Development Operations for Eiger Biopharmaceuticals.
She holds a Ph.D. in Pharmacology and Toxicology from West Virginia University School of Medicine and an MBA from Golden Gate University.
Deb shows American Saddlebred and Morgan horses and is an avid skier.